Group
Núria Montserrat, ICREA Research Professor at the Institute for Bioengineering of Catalonia (IBEC), has been awarded two significant grants totaling 50,000 euros. These funds are intended to support an innovative … Read more
These are asembloids, micrometric organoids formed by the union of kidney organoids with vascular organoids in 3D. These small culture systems are useful for disease modelling and drug screening. The study, led by IBEC, describes an approach that has not been tried before.
Today, the event “Advances in Ataxia Telangiectasia” took place, organized by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with AEFAT, the Spanish ataxia-telangiectasia family association. The gathering brought together patients’ families, researchers, and clinicians to explore the latest advancements in the clinical management of ataxia telangiectasia.
Núria Montserrat Pulido, principal investigator at IBEC, will lead a project to study Ataxia telangiectasia thanks to funding from AEFAT, the Spanish ataxia-telangiectasia family association. The idea of the project is to obtain cells with the patient mutations, develop organoids, explore the possibility of gene editing processes for different mutations and create a platform for drug testing.
